![Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, hydrochloride (1:2)](https://static.cymitquimica.com/products/AN/img/AG00036J.png "Cliquez pour agrandir")
Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, hydrochloride (1:2)
CAS : 1009119-65-6
Ref. AN-AG00036J
| 1g | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté |
Informations sur le produit
Nom :
Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, hydrochloride (1:2)
Synonymes :
- [u'BMS-790052', u'daclatasvir', u'Daklinza', u'Daclatasvir dihydrochloride', u'1009119-65-6', u'BMS-790052 dihydrochloride', u'Daclatasvir (dihydrochloride)', u'BMS-790052-05', u'CHEBI:83800', u'Daklinza', u'BMS 790052', u'UNII-50ZO25C11D', u'BMS 790052-05', u'daclatasvir hydrochloride', u'50ZO25C11D', u'Daclatasvir dihydrochloride (USAN)', u'Daklinza (TN)', u"Dimethyl N,N'-(biphenyl-4,4'-diylbis(1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)))dicarbamate dihydrochloride", u'daclatasvir-dihydrochloride', u'BMS790052 dihydrochloride', u'CHEMBL2303621', u'Daclatasvir hydrochloride (JAN)', u'SCHEMBL17870647', u'BMS 790052 (di HClsalt)', u'BMS-790052 (dihydrochloride)', u'AOB87340', u'MFCD25541736', u'AKOS030632774', u'CS-0270', u'KS-00000P35', u'AC-28423', u'HY-10465', u'Daclatasvir dihydrochloride (BMS-790052)', u'D10105', u'W-6070', u"dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate dihydrochloride", u"Dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate dihydrochloride", u"methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride", u'Daclatasvir 2HCl', u'BMS 790052 dihydrochloride', u'Daclatasvir dihydrochloride [USAN]', u'BMS-790052', u'A11336', u'1009119-64-5', u"N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride"]
- Bms 790052-05
- Carbamic acid, N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester, hydrochloride (1:2)
- Daclatasvir dihydrochloride
- Daclatasvir.2HCL
- Daklinza
- N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride
CAS :
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
811.7969
Formule :
C40H52Cl2N8O6
Degré de pureté :
98%
Couleur/Forme :
Solid
InChI :
InChI=1S/C40H50N8O6.2ClH/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6;;/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52);2*1H/t31-,32-,33-,34-;;/m0../s1
Code InChI :
BVZLLUDATICXCI-JMSCDMLISA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
